167 related articles for article (PubMed ID: 36455397)
1. Sins of omission: A meta-research study evaluating the omission of operability in published retrospective comparisons of surgery with stereotactic body radiotherapy in patients with early-stage non-small cell lung cancer.
Lorenz J; Moghanaki D; Keshava H; Harpole DH; Bradley JD; Higgins KA; Rusthoven CG; Stokes WA
Lung Cancer; 2023 Jan; 175():57-59. PubMed ID: 36455397
[TBL] [Abstract][Full Text] [Related]
2. Association of Operability With Post-Treatment Mortality in Early-Stage Non-Small Cell Lung Cancer.
Stokes WA; Xiong N; Liu Y; Higgins KA; Tian S; Bradley JD; Moghanaki D; Rusthoven CG
Clin Lung Cancer; 2022 May; 23(3):e231-e237. PubMed ID: 35093293
[TBL] [Abstract][Full Text] [Related]
3. Multi-institutional analysis of stereotactic body radiation therapy for operable early-stage non-small cell lung carcinoma.
Kann BH; Verma V; Stahl JM; Ross R; Dosoretz AP; Shafman TD; Gross CP; Park HS; Yu JB; Decker RH
Radiother Oncol; 2019 May; 134():44-49. PubMed ID: 31005223
[TBL] [Abstract][Full Text] [Related]
4. Five-year Long-term Outcomes of Stereotactic Body Radiation Therapy for Operable Versus Medically Inoperable Stage I Non-small-cell Lung Cancer: Analysis by Operability, Fractionation Regimen, Tumor Size, and Tumor Location.
Schonewolf CA; Heskel M; Doucette A; Singhal S; Frick MA; Xanthopoulos EP; Corradetti MN; Friedberg JS; Pechet TT; Christodouleas JP; Levin W; Berman A; Cengel KA; Verma V; Hahn SM; Kucharczuk JC; Rengan R; Simone CB
Clin Lung Cancer; 2019 Jan; 20(1):e63-e71. PubMed ID: 30337269
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic Ablative Radiotherapy as an Alternative to Lobectomy in Patients With Medically Operable Stage I NSCLC: A Retrospective, Multicenter Analysis.
Scotti V; Bruni A; Francolini G; Perna M; Vasilyeva P; Loi M; Simontacchi G; Viggiano D; Lanfranchi B; Gonfiotti A; Topulli J; Olmetto E; Maragna V; Ferrari K; Bonti V; Comin C; Balduzzi S; D'Amico R; Lohr F; Voltolini L; Livi L
Clin Lung Cancer; 2019 Jan; 20(1):e53-e61. PubMed ID: 30348595
[TBL] [Abstract][Full Text] [Related]
6. Retrospective comparison between definitive stereotactic body radiotherapy and radical surgery for 538 patients with early-stage non-small cell lung cancer in a single institution.
Miki Y; Yamashita H; Nakajima J; Karasaki T; Kitano K; Katano A; Takenaka R; Ogita M; Sawayanagi S; Minamitani M; Jinnouchi H; Noyama T; Takeuchi K; Ishida A; Abe O
J Cancer Res Ther; 2023; 19(5):1350-1355. PubMed ID: 37787307
[TBL] [Abstract][Full Text] [Related]
7. A propensity-matched analysis of surgery and stereotactic body radiotherapy for early stage non-small cell lung cancer in the elderly.
Wang P; Zhang D; Guo XG; Li XM; Du LH; Sun BJ; Fang XQ; Guo YH; Guo J; An L; Qu GP; Liu CT
Medicine (Baltimore); 2016 Dec; 95(52):e5723. PubMed ID: 28033277
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Treatment Outcomes Between Thoracoscopic Surgery and Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer.
Tian Q; Zhao X; Zhang C; Tian N; Bian H
Technol Cancer Res Treat; 2024; 23():15330338231219369. PubMed ID: 38378004
[No Abstract] [Full Text] [Related]
9. Overall survival in low-comorbidity patients with stage I non-small cell lung cancer who chose stereotactic body radiotherapy compared to surgery.
Udelsman BV; Canavan ME; Zhan PL; Ely S; Park HS; Boffa DJ; Mase VJ
J Thorac Cardiovasc Surg; 2024 Mar; 167(3):822-833.e7. PubMed ID: 37500052
[TBL] [Abstract][Full Text] [Related]
10. Role of stereotactic body radiotherapy for early-stage non-small-cell lung cancer in patients borderline for surgery due to impaired pulmonary function.
Tomita N; Okuda K; Kita N; Niwa M; Hashimoto S; Murai T; Ishikura S; Nakanishi R; Shibamoto Y
Asia Pac J Clin Oncol; 2022 Dec; 18(6):634-641. PubMed ID: 35098662
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness analysis of stereotactic body radiotherapy and surgery for medically operable early stage non small cell lung cancer.
Paix A; Noel G; Falcoz PE; Levy P
Radiother Oncol; 2018 Sep; 128(3):534-540. PubMed ID: 29706462
[TBL] [Abstract][Full Text] [Related]
12. The role of surgery for stage I non-small cell lung cancer in octogenarians in the era of stereotactic body radiotherapy in the Netherlands.
de Ruiter JC; Heineman DJ; Daniels JM; van Diessen JN; Damhuis RA; Hartemink KJ
Lung Cancer; 2020 Jun; 144():64-70. PubMed ID: 32371262
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of Clinical Outcomes of VATS and SBRT in the Treatment of NSCLC].
Wang J; Zuo Z; Zhang H; Li W; Wang K
Zhongguo Fei Ai Za Zhi; 2016 Mar; 19(3):136-46. PubMed ID: 27009818
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the outcomes of stereotactic body radiotherapy versus surgical treatment for elderly (≥70) patients with early-stage non-small cell lung cancer after propensity score matching.
Dong B; Wang J; Zhu X; Chen Y; Xu Y; Shao K; Zheng L; Ying H; Chen M; Cao J
Radiat Oncol; 2019 Nov; 14(1):195. PubMed ID: 31699115
[TBL] [Abstract][Full Text] [Related]
15. Survival of Primary Stereotactic Body Radiation Therapy Compared With Surgery for Operable Stage I/II Non-small Cell Lung Cancer.
Khorfan R; Kruser TJ; Coughlin JM; Bharat A; Bilimoria KY; Odell DD
Ann Thorac Surg; 2020 Jul; 110(1):228-234. PubMed ID: 32147416
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic body radiotherapy for operable early-stage non-small cell lung cancer.
Eriguchi T; Takeda A; Sanuki N; Tsurugai Y; Aoki Y; Oku Y; Hara Y; Akiba T; Shigematsu N
Lung Cancer; 2017 Jul; 109():62-67. PubMed ID: 28577952
[TBL] [Abstract][Full Text] [Related]
17. Surgical Outcomes for Early Stage Non-small Cell Lung Cancer at Facilities With Stereotactic Body Radiation Therapy Programs.
Syed YA; Stokes W; Rupji M; Liu Y; Khullar O; Sebastian N; Higgins K; Bradley JD; Curran WJ; Ramalingam S; Taylor J; Sancheti M; Fernandez F; Moghanaki D
Chest; 2022 Mar; 161(3):833-844. PubMed ID: 34785235
[TBL] [Abstract][Full Text] [Related]
18. Elderly patients undergoing SBRT for inoperable early-stage NSCLC achieve similar outcomes to younger patients.
Mancini BR; Park HS; Harder EM; Rutter CE; Corso CD; Decker RH; Husain ZA
Lung Cancer; 2016 Jul; 97():22-7. PubMed ID: 27237023
[TBL] [Abstract][Full Text] [Related]
19. A meta-analysis comparing stereotactic body radiotherapy vs conventional radiotherapy in inoperable stage I non-small cell lung cancer.
Li C; Wang L; Wu Q; Zhao J; Yi F; Xu J; Wei Y; Zhang W
Medicine (Baltimore); 2020 Aug; 99(34):e21715. PubMed ID: 32846789
[TBL] [Abstract][Full Text] [Related]
20. Sublobar Resection versus Stereotactic Body Radiation Therapy for Clinical Stage I Non-Small Cell Lung Cancer: A Study Using Data from the Korean Nationwide Lung Cancer Registry.
Yun J; Cho JH; Hong TH; Yang K; Ahn YC; Kim HK; ;
Cancer Res Treat; 2023 Oct; 55(4):1171-1180. PubMed ID: 37080606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]